CD44 and cancer: Since the current procedure for isolation of TICs from human cancer specimens is commonly based on cell surface markers and the ability to form mammospheres, our data suggest that invading/metastasizing TICs may not be identified using these criteria due to a dynamic change in CD44 and mammosphere-forming ability.